BA
UTMD icon

BlackRock Advisors’s Utah Medical Products UTMD Stock Holding History

BlackRock Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$142K Buy
1,947
+16
+0.8% +$1.04K ﹤0.01% 2882
2016
Q3 		$115K Sell
1,931
-150
-7% -$9.54K ﹤0.01% 2963
2016
Q2 		$131K Sell
2,081
-129
-6% -$8.32K ﹤0.01% 2822
2016
Q1 		$138K Buy
2,210
+292
+15% +$17.2K ﹤0.01% 2759
2015
Q4 		$112K Sell
1,918
-806
-30% -$45.7K ﹤0.01% 2873
2015
Q3 		$147K Buy
2,724
+3
+0.1% +$164 ﹤0.01% 2900
2015
Q2 		$162K Buy
2,721
+168
+7% +$9.46K ﹤0.01% 2923
2015
Q1 		$153K Buy
2,553
+348
+16% +$20.5K ﹤0.01% 2835
2014
Q4 		$132K Sell
2,205
-2,404
-52% -$133K ﹤0.01% 2885
2014
Q3 		$225K Hold
4,609
– – ﹤0.01% 2542
2014
Q2 		$237K Buy
4,609
+2,206
+92% +$113K ﹤0.01% 2526
2014
Q1 		$139K Buy
2,403
+97
+4% +$5.29K ﹤0.01% 2865
2013
Q4 		$132K Buy
2,306
+125
+6% +$6.86K ﹤0.01% 2905
2013
Q3 		$130K Buy
2,181
+2
+0.1% +$109 ﹤0.01% 2800
2013
Q2 		$118K Buy
+2,179
New +$103K ﹤0.01% 2784

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BlackRock Advisors's UTMD Position: Q4 2016 in Review

BlackRock Advisors increased its Utah Medical Products (UTMD) stake by 0.83% in Q4 2016, buying an estimated $1.04K and bringing the position to 1,947 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

BlackRock Advisors first reported a position in UTMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $237K in Q2 2014. 75 funds tracked by Wall St. Rank hold UTMD as of Q4 2016.

  • BlackRock Advisors held 1,947 shares of Utah Medical Products worth $142K as of Q4 2016.
  • BlackRock Advisors bought 16 Utah Medical Products shares in Q4 2016, an estimated $1.04K.
  • Utah Medical Products made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2882 holding.
  • BlackRock Advisors first reported a position in Utah Medical Products in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Utah Medical Products position peaked at $237K in Q2 2014.
  • 75 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.